65% surge in Q3 net profit for Divi’s Labs

Hyderabad: Pharma major Divi's Labs on Monday said it recorded a nearly 65% jump in consolidated net profit for the third quarter ended Dec 31, 2024, at 589 crore, compared to 358 crore in the corresponding quarter of the last financial year.
This was on a 25% rise in consolidated revenue from operations for Q3FY25 at 2,319 crore, as against 1,855 crore in Q3FY24. The company said during the quarter it commenced commercial operations from a part of the first phase of its Unit III greenfield project at Ontimamidi village near Kakinada in Andhra Pradesh, from Jan 1, 2025.
However, on a standalone basis, the company clocked a 66% increase in net profit for Q3FY25 at 594 crore, as against 358 crore in the same quarter of last year. This was on a 27% increase in consolidated revenue from operations for Q3FY25 at 2,297 crore, compared to 1,808 crore in Q3FY24.
The company said during the quarter it commenced commercial operations from a part of the first phase of its Unit III greenfield project in Andhra Pradesh